160 related articles for article (PubMed ID: 23686246)
1. Ubiquitin-like domain of IKKβ regulates osteoclastogenesis and osteolysis.
Zhang Y; Otero JE; Abu-Amer Y
Calcif Tissue Int; 2013 Jul; 93(1):78-85. PubMed ID: 23686246
[TBL] [Abstract][Full Text] [Related]
2. Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis.
Darwech I; Otero J; Alhawagri M; Dai S; Abu-Amer Y
J Cell Biochem; 2009 Dec; 108(6):1337-45. PubMed ID: 19830703
[TBL] [Abstract][Full Text] [Related]
3. The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis.
Dai S; Hirayama T; Abbas S; Abu-Amer Y
J Biol Chem; 2004 Sep; 279(36):37219-22. PubMed ID: 15252035
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphorylation is required for IkappaB kinase-beta (IKKbeta) activation and function in osteoclastogenesis.
Darwech I; Otero JE; Alhawagri MA; Abu-Amer Y
J Biol Chem; 2010 Aug; 285(33):25522-30. PubMed ID: 20534585
[TBL] [Abstract][Full Text] [Related]
5. IKKbeta activation is sufficient for RANK-independent osteoclast differentiation and osteolysis.
Otero JE; Dai S; Alhawagri MA; Darwech I; Abu-Amer Y
J Bone Miner Res; 2010 Jun; 25(6):1282-94. PubMed ID: 20200955
[TBL] [Abstract][Full Text] [Related]
6. NEMO-binding domains of both IKKalpha and IKKbeta regulate IkappaB kinase complex assembly and classical NF-kappaB activation.
Solt LA; Madge LA; May MJ
J Biol Chem; 2009 Oct; 284(40):27596-608. PubMed ID: 19666475
[TBL] [Abstract][Full Text] [Related]
7. Defective osteoclastogenesis by IKKbeta-null precursors is a result of receptor activator of NF-kappaB ligand (RANKL)-induced JNK-dependent apoptosis and impaired differentiation.
Otero JE; Dai S; Foglia D; Alhawagri M; Vacher J; Pasparakis M; Abu-Amer Y
J Biol Chem; 2008 Sep; 283(36):24546-53. PubMed ID: 18567579
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory osteolysis is regulated by site-specific ISGylation of the scaffold protein NEMO.
Adapala NS; Swarnkar G; Arra M; Shen J; Mbalaviele G; Ke K; Abu-Amer Y
Elife; 2020 Mar; 9():. PubMed ID: 32202502
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of IKK activation, through sequestering NEMO, blocks PMMA-induced osteoclastogenesis and calvarial inflammatory osteolysis.
Clohisy JC; Yamanaka Y; Faccio R; Abu-Amer Y
J Orthop Res; 2006 Jul; 24(7):1358-65. PubMed ID: 16705717
[TBL] [Abstract][Full Text] [Related]
10. Lysine392, a K63-linked ubiquitination site in NEMO, mediates inflammatory osteoclastogenesis and osteolysis.
Alhawagri M; Yamanaka Y; Ballard D; Oltz E; Abu-Amer Y
J Orthop Res; 2012 Apr; 30(4):554-60. PubMed ID: 21913221
[TBL] [Abstract][Full Text] [Related]
11. A novel ubiquitin-like domain in IkappaB kinase beta is required for functional activity of the kinase.
May MJ; Larsen SE; Shim JH; Madge LA; Ghosh S
J Biol Chem; 2004 Oct; 279(44):45528-39. PubMed ID: 15319427
[TBL] [Abstract][Full Text] [Related]
12. Polyubiquitination events mediate polymethylmethacrylate (PMMA) particle activation of NF-kappaB pathway.
Yamanaka Y; Karuppaiah K; Abu-Amer Y
J Biol Chem; 2011 Jul; 286(27):23735-41. PubMed ID: 21566132
[TBL] [Abstract][Full Text] [Related]
13. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
[TBL] [Abstract][Full Text] [Related]
14. Conditional knockout of PDK1 in osteoclasts suppressed osteoclastogenesis and ameliorated prostate cancer-induced osteolysis in murine model.
Zhang Y; Nong H; Bai Y; Zhou Q; Zhang Q; Liu M; Liu P; Zeng G; Zong S
Eur J Med Res; 2023 Oct; 28(1):433. PubMed ID: 37828580
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling.
Thummuri D; Jeengar MK; Shrivastava S; Nemani H; Ramavat RN; Chaudhari P; Naidu VG
Pharmacol Res; 2015 Sep; 99():63-73. PubMed ID: 26022736
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbeta.
Solt LA; Madge LA; Orange JS; May MJ
J Biol Chem; 2007 Mar; 282(12):8724-33. PubMed ID: 17244613
[TBL] [Abstract][Full Text] [Related]
17. SC-514, a selective inhibitor of IKKβ attenuates RANKL-induced osteoclastogenesis and NF-κB activation.
Liu Q; Wu H; Chim SM; Zhou L; Zhao J; Feng H; Wei Q; Wang Q; Zheng MH; Tan RX; Gu Q; Xu J; Pavlos N; Tickner J; Xu J
Biochem Pharmacol; 2013 Dec; 86(12):1775-83. PubMed ID: 24091016
[TBL] [Abstract][Full Text] [Related]
18. The host antiviral protein SAMHD1 suppresses NF-κB activation by interacting with the IKK complex during inflammatory responses and viral infection.
Yang H; Espada CE; Phillips S; Martinez N; Kenney AD; Yount JS; Xiong Y; Wu L
J Biol Chem; 2023 Jun; 299(6):104750. PubMed ID: 37100289
[TBL] [Abstract][Full Text] [Related]
19. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.
Bharti AC; Takada Y; Aggarwal BB
J Immunol; 2004 May; 172(10):5940-7. PubMed ID: 15128775
[TBL] [Abstract][Full Text] [Related]
20. IKKalpha and IKKbeta each function to regulate NF-kappaB activation in the TNF-induced/canonical pathway.
Adli M; Merkhofer E; Cogswell P; Baldwin AS
PLoS One; 2010 Feb; 5(2):e9428. PubMed ID: 20195534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
